Medications for Postoperative Nausea And Vomiting

86 results

  • Aponvie

    (APREPITANT)
    Heron Therapeutics, Inc.
    Usage: APONVIE is indicated for the prevention of postoperative nausea and vomiting (PONV) in adults. It has not been studied for treating established nausea and vomiting.

  • Barhemsys

    (Amisulpride)
    Acacia Pharma Ltd
    Usage: BARHEMSYS® is indicated for adults to prevent and treat postoperative nausea and vomiting (PONV), either alone or in combination with a different class antiemetic, and for patients who have or have not received prior antiemetic prophylaxis.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine Hydrochloride)
    A-S Medication Solutions
    Usage: This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgical restlessness and apprehension, addressing acute intermittent porphyria, aiding tetanus treatment, relieving manic-depressive symptoms, addressing intractable hiccups, and treating severe behavioral issues in children aged 1 to 12.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine Hydrochloride)
    REMEDYREPACK INC.
    Usage: This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, easing pre-surgical restlessness, acute intermittent porphyria, tetanus adjunct treatment, manic-depressive illness symptoms, intractable hiccups, and severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine hydrochloride)
    Devatis, Inc.
    Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, relieving pre-surgery anxiety, managing acute intermittent porphyria, adjunctive treatment of tetanus, addressing manic episodes, and treating severe behavioral issues in children, including hyperactivity and conduct disorders.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine Hydrochloride)
    REMEDYREPACK INC.
    Usage: The drug is indicated for managing symptoms of psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgical anxiety, addressing acute intermittent porphyria, aiding tetanus treatment, managing manic-depressive illness, relieving intractable hiccups, and treating severe behavioral issues in children aged 1 to 12.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine Hydrochloride)
    Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Usage: This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgical anxiety, and treating acute intermittent porphyria. It also aids in tetanus treatment, addresses manic-depressive illness, relieves intractable hiccups, and treats severe behavioral issues in children aged 1 to 12.

  • Fosaprepitant (fosaprepitant)

    (Fosaprepitant)
    MSN LABORATORIES PRIVATE LIMITED
    Usage: Fosaprepitant for injection is indicated for the prevention of acute and delayed nausea and vomiting in adults and pediatric patients (6 months and older) undergoing highly and moderately emetogenic cancer chemotherapy. It is not studied for treating established nausea and vomiting.

  • Granisetron hydrochloride (granisetron hydrochloride)

    (Granisetron Hydrochloride)
    Breckenridge Pharmaceutical, Inc.
    Usage: Granisetron hydrochloride tablets are indicated for preventing nausea and vomiting related to emetogenic cancer therapy (including high-dose cisplatin) and radiation treatments, such as total body irradiation and fractionated abdominal radiation.

  • Granisetron hydrochloride (granisetron hydrochloride)

    (GRANISETRON HYDROCHLORIDE)
    Wockhardt USA LLC.
    Usage: Granisetron hydrochloride injection is indicated for the prevention of nausea and vomiting related to initial and repeat courses of emetogenic cancer therapy, including those associated with high-dose cisplatin.